Newsfeeds Archive - Spark Newswire

2 minute read

Ex-Humira Growth Platform Drives AbbVie’s Q1 Performance, Drugmaker Lifts Annual Profit Outlook

April 26, 9:54 AM

AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains.

ABBV

2 minute read

Landos Biopharma To Present New Data On Immunometabolism At The 19th Annual Congress Of The European Crohn’s And Colitis Organisation

By Benzinga Newsdesk

January 8, 9:26 AM

Landos Biopharma, Inc. (NASDAQ:LABP) ("Landos" or the "Company"), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced that six abstracts were

LABP

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

June 13, 9:07 AM

Gainers First Wave BioPharma (NASDAQ:FWBI) stock rose 136.5% to $2.7 during Tuesday’s pre-market session. The company’s market cap…

AIH

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

June 8, 9:07 AM

Gainers Aclarion (NASDAQ:ACON) stock increased by 38.5% to $1.44 during Thursday’s pre-market session. The company’s market cap stands…

ACON

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

April 12, 9:06 AM

Gainers Creative Medical Tech (NASDAQ:CELZ) shares increased by 154.1% to $1.23 during Wednesday’s pre-market session. The market value…

AGLE

4 minute read

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank

By Chris Katje

March 11, 3:27 PM

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the company’s Silicon Valley Bank.

AMBA

1 minute read

News

Landos Pharmaceuticals Says Co Maintains A Cash Balance Of ‘Low Single Digit Millions’ With SVB

By Benzinga Newsdesk

March 10, 6:57 PM

-SEC Filing

LABP

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023

By Benzinga Insights

January 6, 11:00 AM

Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…

AGTI

3 minute read

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket

By Lisa Levin

December 30, 7:26 AM

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.

ARBK